戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 er, the smaller ring size represented by the didemnin analogue, tamandarin A, is equipotent to didemn
2 e binding by the unrelated natural products, didemnin and cytotrienin.
3 fications exhibit a parallel effect for both didemnins and tamandarins.
4            Synthetic and naturally occurring didemnins are potent and specific inhibitors of protein
5 two natural products similar in structure to didemnin B (3), were recently isolated from a Brazilian
6       The antineoplastic cyclic depsipeptide didemnin B (DB) inhibits protein synthesis in cells and
7                     The total synthesis of a didemnin B analogue containing a conformationally constr
8 wo conformationally constrained analogues of didemnin B are described.
9 ic analysis of this inhibition revealed that didemnin B inhibits PPT1 uncompetitively.
10    As the first described inhibitor of PPT1, didemnin B may prove to be a useful tool in the investig
11 the protein synthesis inhibitory activity of didemnin B observed at intermediate concentrations.
12 ding site of 1 with the anti-cancer compound didemnin B on EF-1alpha.
13                 Our initial investigation of didemnin B resulted in the discovery of its GTP-dependen
14 of the antiproliferative cyclic depsipeptide didemnin B to PPT1.
15 a indicating that MCF-7 cells can accumulate didemnin B up to 2-3 orders of magnitude compared to the
16              The [N,O-Me(2)Tyr(5)]residue of didemnin B was replaced with L-1,2,3,4-tetrahydroisoquin
17                                              Didemnin B was shown to inhibit recombinant human PPT1 w
18                   The marine natural product didemnin B, currently in clinical trials as an antitumor
19 tostatic and immunosuppressive activities of didemnin B, observed at low concentrations, additional d
20 nin analogue, tamandarin A, is equipotent to didemnin B.
21 es and shown to be slightly more potent than didemnin B.
22  in vitro and in vivo activities compared to didemnin B.
23 rt the purification of a 36-kDa glycosylated didemnin-binding protein from bovine brain lysate.
24 , observed at low concentrations, additional didemnin-binding proteins were sought.
25                          Bioactivities of 42 didemnin congeners, either isolated from the marine tuni
26 uirement for most of the bioactivites of the didemnins, especially for cytotoxicities and antiviral a
27 bition, in vitro binding studies of PPT1 and didemnin indicate that the natural product binds prefere
28 s and in in vivo studies in mice, as well as didemnin M, tested for the mixed lymphocyte reaction and
29 is observation supports tamandarins' role as didemnins' mimic.
30            Immunosuppressive activity of the didemnins was determined using a mixed lymphocyte reacti

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。